Literature DB >> 23716597

A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.

Irene Pérez López1, Luca Cariolato, Darko Maric, Ludovic Gillet, Hugues Abriel, Dario Diviani.   

Abstract

In response to stress, the heart undergoes a remodeling process associated with cardiac hypertrophy that eventually leads to heart failure. A-kinase anchoring proteins (AKAPs) have been shown to coordinate numerous prohypertrophic signaling pathways in cultured cardiomyocytes. However, it remains to be established whether AKAP-based signaling complexes control cardiac hypertrophy and remodeling in vivo. In the current study, we show that AKAP-Lbc assembles a signaling complex composed of the kinases PKN, MLTK, MKK3, and p38α that mediates the activation of p38 in cardiomyocytes in response to stress signals. To address the role of this complex in cardiac remodeling, we generated transgenic mice displaying cardiomyocyte-specific overexpression of a molecular inhibitor of the interaction between AKAP-Lbc and the p38-activating module. Our results indicate that disruption of the AKAP-Lbc/p38 signaling complex inhibits compensatory cardiomyocyte hypertrophy in response to aortic banding-induced pressure overload and promotes early cardiac dysfunction associated with increased myocardial apoptosis, stress gene activation, and ventricular dilation. Attenuation of hypertrophy results from a reduced protein synthesis capacity, as indicated by decreased phosphorylation of 4E-binding protein 1 and ribosomal protein S6. These results indicate that AKAP-Lbc enhances p38-mediated hypertrophic signaling in the heart in response to abrupt increases in the afterload.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716597      PMCID: PMC3719681          DOI: 10.1128/MCB.00031-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 2.  Modulation of cardiac function by A-kinase anchoring proteins.

Authors:  Dario Diviani
Journal:  Curr Opin Pharmacol       Date:  2007-12-31       Impact factor: 5.547

3.  AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.

Authors:  Graeme K Carnegie; Joseph Soughayer; F Donelson Smith; Benjamin S Pedroja; Fang Zhang; Dario Diviani; Michael R Bristow; Maya T Kunkel; Alexandra C Newton; Lorene K Langeberg; John D Scott
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

4.  The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.

Authors:  Jinliang Li; Alejandra Negro; Johanna Lopez; Andrea L Bauman; Edward Henson; Kimberly Dodge-Kafka; Michael S Kapiloff
Journal:  J Mol Cell Cardiol       Date:  2009-10-31       Impact factor: 5.000

5.  Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Authors:  Hiromitsu Takagi; Chiao-Po Hsu; Katsuya Kajimoto; Dan Shao; Yanfei Yang; Yasuhiro Maejima; Peiyong Zhai; Ghassan Yehia; Chikaomi Yamada; Daniela Zablocki; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

6.  MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.

Authors:  John M Streicher; Shuxun Ren; Harvey Herschman; Yibin Wang
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

7.  AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.

Authors:  F Donelson Smith; Lorene K Langeberg; Cristina Cellurale; Tony Pawson; Deborah K Morrison; Roger J Davis; John D Scott
Journal:  Nat Cell Biol       Date:  2010-11-21       Impact factor: 28.824

Review 8.  Signal integration through blending, bolstering and bifurcating of intracellular information.

Authors:  Catherine T Pawson; John D Scott
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

9.  The A-kinase anchor protein AKAP121 is a negative regulator of cardiomyocyte hypertrophy.

Authors:  Bernard Abrenica; Mohamed AlShaaban; Michael P Czubryt
Journal:  J Mol Cell Cardiol       Date:  2009-05       Impact factor: 5.000

10.  The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.

Authors:  Aline Appert-Collin; Susanna Cotecchia; Monique Nenniger-Tosato; Thierry Pedrazzini; Dario Diviani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

View more
  19 in total

1.  Common functional variants of the glutamatergic system in Autism spectrum disorder with high and low intellectual abilities.

Authors:  Andreas G Chiocchetti; Afsheen Yousaf; Hannah S Bour; Denise Haslinger; Regina Waltes; Eftichia Duketis; Tomas Jarczok; Michael Sachse; Monica Biscaldi; Franziska Degenhardt; Stefan Herms; Sven Cichon; Jörg Ackermann; Ina Koch; Sabine M Klauck; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2017-11-16       Impact factor: 3.575

2.  A-kinase anchoring protein 8L interacts with mTORC1 and promotes cell growth.

Authors:  Chase H Melick; Delong Meng; Jenna L Jewell
Journal:  J Biol Chem       Date:  2020-04-20       Impact factor: 5.157

3.  AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism.

Authors:  Miranda M Sung; Beshay N Zordoky; Adam L Bujak; James S V Lally; David Fung; Martin E Young; Sandrine Horman; Edward J Miller; Peter E Light; Bruce E Kemp; Gregory R Steinberg; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2015-05-28       Impact factor: 10.787

Review 4.  Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Authors:  Moriah Gildart; Michael S Kapiloff; Kimberly L Dodge-Kafka
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

Review 5.  AKAP signaling complexes: pointing towards the next generation of therapeutic targets?

Authors:  Jessica L Esseltine; John D Scott
Journal:  Trends Pharmacol Sci       Date:  2013-11-12       Impact factor: 14.819

6.  Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.

Authors:  Jun-Biao Wu; Yuan Zhou; Chun-Ling Liang; Xiao-Jun Zhang; Jie-Mei Lai; Shu-Fang Ye; Hui Ouyang; Jin Lin; Jiu-Yao Zhou
Journal:  Chin J Integr Med       Date:  2016-03-17       Impact factor: 1.978

7.  The crystal structure of the RhoA-AKAP-Lbc DH-PH domain complex.

Authors:  Kamal R Abdul Azeez; Stefan Knapp; João M P Fernandes; Enno Klussmann; Jonathan M Elkins
Journal:  Biochem J       Date:  2014-12-01       Impact factor: 3.857

8.  Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.

Authors:  Asvi A Francois; Kofo Obasanjo-Blackshire; James E Clark; Andrii Boguslavskyi; Mark R Holt; Peter J Parker; Michael S Marber; Richard J Heads
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

Review 9.  Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins.

Authors:  Ana I Calejo; Kjetil Taskén
Journal:  Front Pharmacol       Date:  2015-09-08       Impact factor: 5.810

Review 10.  A-Kinase Anchoring Protein-Lbc: A Molecular Scaffold Involved in Cardiac Protection.

Authors:  Dario Diviani; Halima Osman; Erica Reggi
Journal:  J Cardiovasc Dev Dis       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.